Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$1.37
NASDAQLPCN
Open
$1.33
Change
$0.03 (2.24%)
Day's Range
$1.33 - $1.38
52-Week Range
$0.90 - $2.42
Volume
511.0K
Market Cap
$121.0M